Loaiza-Bonilla Offers Guidance on Optimizing Treatment Selection in Pancreatic Cancer

Season 5 Episode 41  ·  Sep 13, 2021, 04:56 PM
Headliner
Share
Subscribe

Dr. Loaiza-Bonilla discusses approaches to frontline treatment selection in metastatic pancreatic cancer, the effects of adverse effects and toxicities in treatment planning, and treatment options available to patients post gemcitabine-based regimens.

Share
Subscribe
Next
Neel on Maximizing Research Strides in Oncology
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air